Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $17,555 | 20 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $15,555 | 19 | $0 (2024) |
| Actelion Clinical Research, Inc. | $2,000 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,055 | 12 | Merck Sharp & Dohme LLC ($5,055) |
| 2023 | $7,875 | 2 | Merck Sharp & Dohme LLC ($7,875) |
| 2022 | $1,625 | 2 | Merck Sharp & Dohme LLC ($1,625) |
| 2021 | $1,000 | 3 | Merck Sharp & Dohme LLC ($1,000) |
| 2017 | $2,000 | 1 | Actelion Clinical Research, Inc. ($2,000) |
All Payment Transactions
20 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $622.20 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/16/2024 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $603.90 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/16/2024 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $603.90 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/09/2024 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $414.80 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/09/2024 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $402.60 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/09/2024 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $402.60 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/16/2024 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $311.10 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/16/2024 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $301.95 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/16/2024 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $301.95 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/05/2024 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $370.60 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/05/2024 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $359.70 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/05/2024 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $359.70 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/11/2023 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $3,937.50 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 09/11/2023 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $3,937.50 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 06/29/2022 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $1,249.95 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 06/29/2022 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $375.05 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 12/10/2021 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $750.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 07/14/2021 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $125.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 07/14/2021 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $125.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 03/23/2017 | Actelion Clinical Research, Inc. | — | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 89 | 142 | $38,444 | $11,295 |
| 2022 | 2 | 43 | 72 | $17,377 | $5,471 |
| 2021 | 2 | 48 | 64 | $12,055 | $3,891 |
| 2020 | 5 | 86 | 140 | $33,516 | $11,344 |
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 13 | 49 | $10,650 | $3,318 | 31.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 19 | 28 | $9,044 | $2,851 | 31.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 26 | 33 | $8,633 | $2,520 | 29.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 12 | 12 | $6,677 | $1,689 | 25.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 19 | 20 | $3,439 | $917.17 | 26.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 31 | 49 | $10,722 | $3,460 | 32.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 12 | 23 | $6,655 | $2,011 | 30.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 30 | 42 | $8,992 | $2,956 | 32.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 18 | 22 | $3,062 | $935.20 | 30.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 18 | 38 | $9,309 | $3,434 | 36.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 17 | 38 | $6,493 | $2,383 | 36.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 11 | 11 | $5,593 | $1,941 | 34.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 24 | 33 | $6,504 | $1,867 | 28.7% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 16 | 20 | $5,618 | $1,719 | 30.6% |
About Robert Harrington
Robert Harrington is a Infectious Disease healthcare provider based in Seattle, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1912083718.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Robert Harrington has received a total of $17,555 in payments from pharmaceutical and medical device companies, with $5,055 received in 2024. These payments were reported across 20 transactions from 2 companies. The most common payment nature is "Consulting Fee" ($17,555).
As a Medicare-enrolled provider, Harrington has provided services to 266 Medicare beneficiaries, totaling 418 services with total Medicare billing of $32,002. Data is available for 4 years (2020–2023), covering 14 distinct procedure/service records.
Practice Information
- Specialty Infectious Disease
- Location Seattle, WA
- Active Since 10/27/2006
- Last Updated 12/28/2012
- Taxonomy Code 207RI0200X
- Entity Type Individual
- NPI Number 1912083718
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Infectious Disease Doctors in Seattle
Michael Cairns, Md, MD
Infectious Disease — Payments: $308,064
Warren Dinges, Md, Phd, MD, PHD
Infectious Disease — Payments: $250,418
Dr. Lynn Frumkin, M.d, M.D
Infectious Disease — Payments: $176,898
Paul Drain, M.d, M.D
Infectious Disease — Payments: $123,764
Michael Boeckh, Md, MD
Infectious Disease — Payments: $91,595
Anna Wald, Md Mph, MD MPH
Infectious Disease — Payments: $91,393